1,721,204 research outputs found
Senior Recital - Kaelan Harris-Patrick
Full text linkProgram for Kaelan Harris-Patrick\u27s Senior Recital.https://digitalcommons.kennesaw.edu/musicprograms/2466/thumbnail.jp
Harris, Patrick Joseph, VX48683
No full textThis record was harvested from a previous catalogue system and will be withdrawn in 2025. Information in this record may be superseded or incomplete. Visit this record in UMA's new catalogue at: https://archives.library.unimelb.edu.au/nodes/view/390693Surname: HARRIS. Given Name(s) or Initials: PATRICK JOSEPH. Military Service Number or Last Known Location: VX48683. Missing, Wounded and Prisoner of War Enquiry Card Index Number: 22235.215462
Item: [2016.0049.22986] "Harris, Patrick Joseph, VX48683
Dominance of ST131 Escherichia coli carrying blaCTX-M in patients with bloodstream infections caused by cephalosporin-resistant strains in Australia, New Zealand and Singapore: whole genome analysis of isolates from a randomised trial
No full textThis dataset includes the clinical and genomic data associated with 3rd generation cephalosporin-resistant E. coli strains cultured from patients enrolled in an international randomised controlled trial (the MERINO Trial)
Dominance of ST131 Escherichia coli carrying blaCTX-M in patients with bloodstream infections caused by cephalosporin-resistant strains in Australia, New Zealand and Singapore: whole genome analysis of isolates from a randomised trial
No full textThis dataset includes the clinical and genomic data associated with 3rd generation cephalosporin-resistant E. coli strains cultured from patients enrolled in an international randomised controlled trial (the MERINO Trial)
Risk factors for relapse or persistence of bacteraemia caused by Enterobacter spp.: a case-control study
No full textEnterobacter spp. possess chromosomal AmpC beta-lactamases that may be expressed at high levels. Previous studies have demonstrated a risk of relapsed bacteraemia following therapy with third generation cephalosporins (3GCs). What additional factors predict microbiological failure in Enterobacter bacteraemia is unclear. We aimed to determine factors associated with microbiological failure in Enterobacter bacteraemia, and retrospectively identified cases of bacteraemia caused by Enterobacter spp. occurring in four hospitals in New South Wales and Queensland, Australia. Using a case-control design, we determined clinical risk factors for persistence or relapse defined as repeated positive blood cultures collected between 72 hours and up to 28 days post initial positive blood culture
Risk factors for relapse or persistence of bacteraemia caused by Enterobacter spp.: a case-control study
No full textEnterobacter spp. possess chromosomal AmpC beta-lactamases that may be expressed at high levels. Previous studies have demonstrated a risk of relapsed bacteraemia following therapy with third generation cephalosporins (3GCs). What additional factors predict microbiological failure in Enterobacter bacteraemia is unclear. We aimed to determine factors associated with microbiological failure in Enterobacter bacteraemia, and retrospectively identified cases of bacteraemia caused by Enterobacter spp. occurring in four hospitals in New South Wales and Queensland, Australia. Using a case-control design, we determined clinical risk factors for persistence or relapse defined as repeated positive blood cultures collected between 72 hours and up to 28 days post initial positive blood culture
Clinical implementation of routine whole-genome sequencing for hospital infection control of multi-drug resistant pathogens
No full textSupplementary table to describe clinical meta-data associated with genomes of multi-drug resistant bacteria identified in Queensland hospital
Risk factors for relapse or persistence of bacteraemia caused by Enterobacter spp.: a case-control study
No full textResults of case-control design study for risk factors associated with relapse or persistence of bacteraemia caused by Enterobacter spp. We determined clinical risk factors for persistence or relapse defined as repeated positive blood cultures collected between 72 hours and up to 28 days post initial positive blood culture
Clinical meta-data from patients with bloodstream infections caused by 3GC-resistant E. coli
No full textThis dataset includes the clinical and genomic data associated with 3rd generation cephalosporin-resistant E. coli strains cultured from patients enrolled in an international randomised controlled trial (the MERINO Trial). 
- …
